recent publications

• academic article

  • Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., Ahn, H. J., Ait-Mohamed, O., et al. Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy  2012 8:445-544  DOI:10.4161/auto.19496  PMID:22966490  PMCID:PMC3404883
  • Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S. C., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., Grandis, J. R. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth Proceedings of the National Academy of Sciences of the United States of America  2003 100:4138-4143  DOI:10.1073/pnas.0534764100  PMID:12640143  PMCID:PMC153061
  • Johnson, D. E., Lee, P. L., Lu, J., Williams, L. T. Diverse forms of a receptor for acidic and basic fibroblast growth-factors Molecular and Cellular Biology  1990 10:4728-4736  PMID:2167437  PMCID:PMC361071
  • Lee, P. L., Johnson, D. E., Cousens, L. S., Fried, V. A., Williams, L. T. Purification and complementary-DNA cloning of a receptor for basic fibroblast growth-factor Science  1989 245:57-60  DOI:10.1126/science.2544996  PMID:2544996
  • Shawler, D. L., Johnson, D. E., Sweet, M. D., Myers, L. J., Tudor, S. D., Beidler, D. E., Koziol, J. A., Dillman, R. O. Preclinical trials using an immunoconjugate of t101 and methotrexate in an athymic mouse human t-cell tumor-model Journal of Biological Response Modifiers  1988 7:608-618  PMID:3265148
  • Dillman, R. O., Johnson, D. E., Shawler, D. L., Koziol, J. A. Superiority of an acid-labile daunorubicin monoclonal antibody immunoconjugate compared to free drug Cancer Research  1988 48:6097-6102  PMID:3262420
  • Dillman, R. O., Shawler, D. L., Johnson, D. E., Meyer, D. L., Koziol, J. A., Frincke, J. M. Preclinical trials with combinations and conjugates of t101 monoclonal-antibody and doxorubicin Cancer Research  1986 46:4886-4891  PMID:2428468